Factor I Antibodies

Santa Cruz Biotechnology offers a broad range of Factor I Antibodies for research focused on understanding the regulation of the complement system. Factor I Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Factor I is a crucial serine protease that plays a significant role in the regulation of the complement pathway, helping to prevent excessive inflammation and tissue damage. By cleaving and inactivating complement components, Factor I ensures a balanced immune response, making it essential for maintaining homeostasis and preventing autoimmune disorders. Understanding Factor I function is vital for developing therapeutic strategies targeting complement-related diseases. Factor I research has revealed important insights into immune system regulation and inflammatory responses. Ongoing studies continue to uncover new aspects of Factor I's role in maintaining immune system balance. Factor I monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance our understanding of complement system biology and its impact on human health.